Top Markets
#1 PulseChain PulseChain +43.68%
#2 Bitway Bitway +9.64%
#3 Meteora Meteora +8.38%
#4 Velvet Velvet +7.60%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.15%
#6 eCash eCash +6.72%
#7 Fake World Assets Fake World Assets +6.06%
#8 Bitcoin SV Bitcoin SV +5.96%
#9 Cash Cat Cash Cat +5.45%
#10 Rocket Pool Rocket Pool +5.30%
Coin of the day
PulseChain PulseChain
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
शेयरों में रैंक #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
शेयर मूल्य
$0.07339369
अंतिम समन्वयन: 2026-08-18
मार्केट कैप
$25.24M
बदलाव (1 दिन)
5.26%
बदलाव (1 वर्ष)
-7.44%
देश
CA
व्यापार Resverlogix Corp. (RVX)

श्रेणी

Healthcare
Resverlogix Corp. (RVX) के लिए P/S अनुपात
2026 को P/S अनुपात TTM: 0
Resverlogix Corp. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/S अनुपात 0 था।
Resverlogix Corp. के लिए 2026 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH